Together with the fact that tumor heterogeneity was not significantly lower in AR high tumors in the ER-positive BC cohort, the relationship between AR expression and TIL does not follow the dogma that heterogeneous tumor produces neoantigens that attract TILs [34]. The gene discussed is AR; the disease is breast cancer.